Related Experiment Video
Updated: Apr 6, 2026

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Case Report: Pulmonary Alveolar Calcification as a Result of Severe Hypercalcemia due to Acute Lymphoblatic Leukemia
Jose Colleti Junior1, Eliana Carla Armelin Benites2, Gustavo Spadaccia Dos Santos Fernandes3
1Pediatric Intensive Care Unit, Santa Catarina Hospital , São Paulo, 01310 000, Brazil.
Insights
Severe hypercalcemia in a toddler, a rare metabolic disorder, was successfully treated with pamidronate. This case highlights hypercalcemia as a potential early sign of acute lymphoblastic leukemia (ALL).
Area of Science:
- Pediatric Endocrinology
- Pediatric Oncology
- Metabolic Disorders
Background:
- Severe hypercalcemia is an uncommon metabolic disorder in children.
- It can present with significant clinical manifestations and radiological findings, including osteolytic lesions and pulmonary calcification.
- Hypercalcemia as an initial presentation of acute lymphoblastic leukemia (ALL) is rare.
Purpose of the Study:
- To report a rare case of severe hypercalcemia in a pediatric patient.
- To describe the clinical and radiological features associated with severe hypercalcemia.
- To emphasize the importance of considering ALL in cases of unexplained severe hypercalcemia.
Main Methods:
- Case report of a 2-year-old toddler with severe hypercalcemia.
- Clinical evaluation, radiological imaging (osteolytic lesions, pulmonary alveolar calcification).
- Treatment with pamidronate (a bisphosphonate) and subsequent diagnostic workup for underlying causes.
Main Results:
- The patient presented with severe hypercalcemia, osteolytic lesions, and massive pulmonary alveolar calcification.
- Pamidronate effectively managed the hypercalcemia.
- Further investigations revealed a diagnosis of acute lymphoblastic leukemia (ALL).
Conclusions:
- Severe hypercalcemia can be a presenting sign of acute lymphoblastic leukemia (ALL) in pediatric patients.
- Radiological findings can be indicative of hypercalcemia-induced complications.
- Prompt diagnosis and treatment, including bisphosphonates for hypercalcemia and chemotherapy for ALL, are crucial for favorable outcomes.
Abstract:
Severe hypercalcemia is a rare metabolic disorder in pediatric medicine. This report describes a rare case of severe hypercalcemia and its clinical manifestations in a 2-year-old toddler. The radiological findings caused by hypercalcemia and osteolysis were emblematic of the osteolytic lesions. Hypercalcemia led to massive pulmonary alveolar calcification. The hypercalcemia was successfully treated with pamidronate, a bisphosphonate drug class. Further investigation resulted in a diagnosis of acute lymphoblastic leukemia (ALL). The patient is currently on chemotherapy and has a favorable prognosis. Although severe hypercalcemia alone is an unusual finding as the first sign for ALL, this should be considered, not to mention the radiological images resulted from calcium deposits.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Acute Respiratory Failure-III
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
